文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

免疫抑制脓毒症患者28天死亡率的回顾性队列研究:基于MIMIC-IV V2.2的可解释性预测模型

A Retrospective Cohort Study on 28-Day Mortality in Immunosuppressed Sepsis: An Interpretability-Based Predictive Model Using MIMIC-IV V2.2.
PubMed 文献 · Shock · 2025-09-12
一句话结论在免疫抑制脓毒症患者中,基于乳酸、红细胞分布宽度、血小板计数和SOFA评分的XGBoost模型预测28天死亡率AUROC为0.93(95%CI 0.90-0.96)。

本研究为回顾性队列研究,使用MIMIC-IV V2.2数据库中免疫抑制脓毒症患者的临床、实验室和人口学数据,通过LASSO回归进行特征选择,开发了包括XGBoost在内的预测模型。最终模型识别出乳酸水平、红细胞分布宽度、血小板计数和序贯器官衰竭评估评分为28天死亡率的关键预测因子。XGBoost表现出优越的预测准确性,AUROC为0.93(95%CI 0.90-0.96),优于其他模型。SHAP分析显示,乳酸水平升高和血小板计数降低是死亡的强危险因素,而乳酸水平较低和血小板计数较高具有保护作用。该模型的可解释性为个体化风险分层提供了清晰见解。

要点

  • 在免疫抑制脓毒症患者中,XGBoost模型预测28天死亡率的AUROC为0.93(95%CI 0.90-0.96),优于其他模型。
  • 关键预测因子包括乳酸水平、红细胞分布宽度、血小板计数和序贯器官衰竭评估评分。
  • SHAP分析显示乳酸水平升高和血小板计数降低是死亡的强危险因素,乳酸水平较低和血小板计数较高具有保护作用。
  • 模型的可解释性有助于个体化风险分层,为临床决策提供透明见解。

适用人群与场景

  • 免疫抑制脓毒症患者,数据来自MIMIC-IV V2.2数据库。

研究设计与关键结果

  • 回顾性队列研究,使用MIMIC-IV V2.2数据库中免疫抑制脓毒症患者的临床、实验室和人口学数据,通过LASSO回归进行特征选择,开发包括XGBoost在内的预测模型。
  • 最终模型识别出乳酸水平、红细胞分布宽度、血小板计数和序贯器官衰竭评估评分为28天死亡率的关键预测因子。
  • XGBoost预测28天死亡率的AUROC为0.93(95%CI 0.90-0.96),优于其他模型。
  • SHAP分析显示乳酸水平升高和血小板计数降低是死亡的强危险因素,乳酸水平较低和血小板计数较高具有保护作用。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,XGBoost模型结合SHAP分析可为免疫抑制脓毒症患者提供准确且可解释的28天死亡率预测工具,通过透明呈现死亡风险驱动因素增强临床决策,支持个体化和及时干预以改善患者结局。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Sepsis in immunosuppressed patients is associated with significantly higher mortality rates, yet predictive models tailored to this high-risk population remain limited. This study aims to develop an interpretable machine learning model to predict 28-day mortality in immunosuppressed sepsis patients, with a focus on model transparency and clinical applicability.

METHODS: A retrospective cohort study was conducted using clinical, laboratory, and demographic data from immunosuppressed sepsis patients. Feature selection was performed using LASSO regression, followed by the development of predictive models, including XGBoost. The model's performance was evaluated using the area under the receiver operating characteristic curve (AUROC). To enhance clinical interpretability, Shapley additive explanations (SHAP) were employed to provide insights into the contribution of individual features to mortality predictions.

RESULTS: The final model identified key predictors of 28-day mortality, including lactate levels, red cell distribution width, platelet count, and Sequential Organ Failure Assessment score. XGBoost demonstrated superior predictive accuracy with an AUROC of 0.93 (95% confidence interval: 0.90-0.96), outperforming other models. SHAP analysis revealed that elevated lactate levels and reduced platelet counts were strong risk factors for mortality, while lower lactate and higher platelet counts were protective. The model's interpretability provided clear insights into the role of each predictor, facilitating individualized risk stratification.

CONCLUSION: The XGBoost model, combined with SHAP analysis, offers an accurate and interpretable tool for predicting 28-day mortality in immunosuppressed sepsis patients. This approach enhances clinical decision-making by providing transparent insights into the factors driving mortality risk, thus supporting personalized and timely interventions aimed at improving patient outcomes.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Zhong Z, He H, Lin Z, et al. A Retrospective Cohort Study on 28-Day Mortality in Immunosuppressed Sepsis: An Interpretability-Based Predictive Model Using MIMIC-IV V2.2. Shock. 2025. PMID: 40997317. doi:10.1097/SHK.0000000000002721

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。